Lineage Cell Therapeutics (LCTX) Change in Receivables (2010 - 2026)
Lineage Cell Therapeutics (LCTX) posted Change in Receivables of -$19,000 for Q2 2026, compared with $43,000 a year earlier.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Change in Receivables (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Receivables at Lineage Cell Therapeutics was $524,000; for FY2025, it came in at $316,000.
- In prior years, Lineage Cell Therapeutics' Change in Receivables was -$106,000 in FY2024, $446,000 in FY2023, -$50.31 million in FY2022 and $857,000 in FY2021.
- Quarterly Change in Receivables has run from a low of -$50.32 million in Q1 2022 to a high of $827,000 in Q4 2025 over five years.
- According to Business Quant data, Change in Receivables for the three prior quarters was -$154,000 (Q1 2026), $827,000 (Q4 2025) and -$130,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Lineage Cell Therapeutics | 240.26 Mn | 38.67 Mn | - | -19,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19,000.00 |
| Mar 31, 2026 | -154,000.00 |
| Dec 31, 2025 | 827,000.00 |
| Sep 30, 2025 | -130,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Mar 31, 2025 | -424,000.00 |
| Dec 31, 2024 | 233,000.00 |
| Sep 30, 2024 | 169,000.00 |
| Jun 30, 2024 | 160,000.00 |
| Mar 31, 2024 | -668,000.00 |
| Dec 31, 2023 | 305,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | 242,000.00 |
| Mar 31, 2023 | -95,000.00 |
| Dec 31, 2022 | -108,000.00 |
| Sep 30, 2022 | -95,000.00 |
| Jun 30, 2022 | 210,000.00 |
| Mar 31, 2022 | -50.32 Mn |
| Dec 31, 2021 | 753,000.00 |
| Sep 30, 2021 | -249,000.00 |
API Access
Lineage Cell Therapeutics Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();